A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve ...

For the first time in 30 years, the Food and Drug Administration has approved a new treatment for an inoperable type of pancreatic cancer​.

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Clinical trial led by UAB researcher supports approval of new, potentially curative treatment for multiple myeloma ...

The combination of Roche’s investigational drug, giredestrant, with Pfizer’s Ibrance didn’t lead to a statistically significant improvement among patients with advanced breast cancer.

After getting engaged, the only words journalist Mrinali Dhembla expected to hear were “I do.” Instead, she was told, “You have cancer.” “When I first heard the words, ‘You have cancer,’ I was ...

The alternative medicine industry is expanding rapidly, fueled in large part by the surge of health-related content on social ...

New research suggests childhood cancer survivors may experience accelerated biological aging from treatments, potentially ...

Many therapeutic molecules used in cancer treatments are highly toxic, often harming healthy tissues and causing significant ...